Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well. However, they can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.
One such company that might be well-positioned for future earnings growth is ABIOMED, Inc. (ABMD - Free Report) . This firm, which is in the Medical - Instruments industry, saw EPS growth of 109.4% last year, and is looking great for this year too.
In fact, the current growth estimate for this year calls for earnings-per-share growth of 40.1%. Furthermore, the long-term growth rate is currently an impressive 27%, suggesting pretty good prospects for the long haul.
ABIOMED, Inc. Price and Consensus
And if this wasn’t enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 6.2%. Thanks to this rise in earnings estimates, ABMD has a Zacks Rank #1 (Strong Buy) which further underscores the potential for outperformance in this company. You can see the complete list of today’s Zacks #1 Rank stocks here.
So, if you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider ABMD. Not only does it have double-digit earnings growth prospects, but its impressive Zacks Rank suggests that analysts believe better days are ahead for ABMD as well.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>